We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
-11.04%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$175M
AUM Growth
-$20.2M
Cap. Flow
+$10.1M
Cap. Flow %
5.76%
Top 10 Hldgs %
36.8%
Holding
85
New
16
Increased
25
Reduced
11
Closed
19

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$3.77M
2
VAR
Varian Medical Systems, Inc.
VAR
+$3.33M
3
BSX icon
Boston Scientific
BSX
+$3.08M
4
ELGX
Endologix Inc
ELGX
+$2.78M
5
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$2.76M

Top Sells

Rank Stock Value
1
SIEN
Sientra, Inc.
SIEN
+$5.61M
2
ALIM
Alimera Sciences
ALIM
+$4.5M
3
SPNC
Spectranetics Corp
SPNC
+$4.48M
4
COO icon
Cooper Companies
COO
+$4.42M
5
CPHD
Cepheid Inc
CPHD
+$3.33M

Sector Composition

Rank Sector Weight
1 Healthcare 65.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CI icon
1
Cigna
CI
$74.6B
$8.24M 4.7%
61,000
-4,000
-6% -$581K
UHS icon
2
Universal Health Services
UHS
$10.2B
$8.09M 4.62%
64,800
+4,800
+8% +$668K
TFX icon
3
Teleflex
TFX
$6.19B
$7.14M 4.08%
57,500
+8,700
+18% +$1.16M
SYK icon
4
Stryker
SYK
$131B
$7.06M 4.03%
75,000
+25,000
+50% +$2.48M
BSX icon
5
Boston Scientific
BSX
$72B
$6.81M 3.89%
415,000
+180,000
+77% +$3.08M
TFX icon
6
CALL
Teleflex
TFX
$6.19B
$6.21M 3.54%
50,000
– –
PFE icon
7
Pfizer
PFE
$143B
$6.12M 3.49%
205,398
+55,203
+37% +$1.77M
SNN icon
8
CALL
Smith & Nephew
SNN
$13.5B
$5.25M 3%
+150,000
New +$5.35M
NXTM
9
DELISTED
NxStage Medical Inc.
NXTM
$4.89M 2.79%
310,000
+49,800
+19% +$798K
PODD icon
10
Insulet
PODD
$11.8B
$4.68M 2.67%
180,600
+80,600
+81% +$2.44M
JNJ icon
11
PUT
Johnson & Johnson
JNJ
$613B
$4.67M 2.66%
+50,000
New +$4.84M
WMGI
12
DELISTED
Wright Medical Group Inc
WMGI
$4.42M 2.52%
210,101
+90,000
+75% +$2.24M
BHC icon
13
Bausch Health
BHC
$2.62B
$4.13M 2.35%
23,125
+10,625
+85% +$2.48M
ABBV icon
14
AbbVie
ABBV
$433B
$4.03M 2.3%
74,000
+16,625
+29% +$1.08M
HOLX
15
CALL
DELISTED
Hologic
HOLX
$3.91M 2.23%
+100,000
New +$3.97M
LLY icon
16
Eli Lilly
LLY
$1,000B
$3.7M 2.11%
44,250
+17,750
+67% +$1.5M
CYBX
17
DELISTED
CYBERONICS INC
CYBX
$3.65M 2.08%
60,000
– –
ARAY icon
18
Accuray
ARAY
$32.4M
$3.56M 2.03%
713,700
+333,700
+88% +$2.14M
NUVA
19
DELISTED
NuVasive, Inc.
NUVA
$3.51M 2%
72,780
-21,359
-23% -$1.1M
SPNC
20
CALL
DELISTED
Spectranetics Corp
SPNC
$3.42M 1.95%
290,000
+215,000
+287% +$3.85M
ABT icon
21
Abbott
ABT
$185B
$3.22M 1.84%
+80,000
New +$3.77M
BMY icon
22
Bristol-Myers Squibb
BMY
$134B
$3.18M 1.82%
53,750
+3,125
+6% +$198K
CYNA
23
DELISTED
CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
$3.1M 1.77%
194,461
– –
VAR
24
DELISTED
Varian Medical Systems, Inc.
VAR
$2.95M 1.68%
+45,615
New +$3.33M
VNDA icon
25
Vanda Pharmaceuticals
VNDA
$315M
$2.79M 1.59%
247,500
-60,000
-20% -$734K
1
2 3 4

Similar funds

GMP
Great Mountain Partners New Haven, Connecticut $15.1M AUM 92.9% 1-Year Est. Return
BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SRA
Summit Rock Advisors New York $16M AUM
SR
Swiss Re Zurich, Switzerland $16.4M AUM
TC
TradeLink Capital Chicago, Illinois $13.2M AUM 33.27% 1-Year Est. Return

Pura Vida Investments's Q3 2015 Portfolio in Review

As of Q3 2015, Pura Vida Investments held 85 positions worth $175M, down 10% from $195M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Pura Vida Investments deployed $10.1M of net new capital in Q3 2015, opening 16 new positions and adding to 25 existing holdings. Its largest new stake was Abbott: 80,000 shares worth $3.22M.

By sector, the portfolio is most concentrated in Healthcare at 66% of assets, down from 70% a quarter earlier.

On the sell side, the largest reduction was Alimera Sciences, an estimated $4.5M trimmed.

  • Pura Vida Investments's largest Q3 2015 buy was Abbott: 80,000 shares worth $3.22M.
  • Pura Vida Investments added most to Boston Scientific in Q3 2015, an estimated $3.08M increase.
  • Pura Vida Investments's biggest Q3 2015 reduction was Alimera Sciences, cutting an estimated $4.5M.
  • Pura Vida Investments fully exited Sientra, Inc. in Q3 2015, selling an estimated $5.61M.
  • Pura Vida Investments's ten largest holdings make up 37% of its $175M portfolio in Q3 2015.
  • Pura Vida Investments opened 16 new positions and closed 19 in Q3 2015.
  • Pura Vida Investments's portfolio value fell 10% quarter-over-quarter to $175M.

Based on Pura Vida Investments's 13F filing for Q3 2015, filed 16 Nov 2015.